- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bio-Techne Corp (TECH)
Assess today's live Bio-Techne Corp (TECH) share price, performance and insights using our live NASDAQ: TECH stock exchange data.
Analyse the historical data and Bio-Techne Corp share price performance charts on this page. Our technical summary section provides analysis on Bio-Techne share price buy/sell indicators using real-time data (or discuss the Bio-Techne (TECH) stock price today with other investors in the Bio-Techne NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TECH share price (ISIN: US09073M1045) to enhance your trading decisions with our free investment tools and resources.
What Is the Bio-Techne Corp Share Price Today?
The Bio-Techne share price today is 50.91.
What Is the Stock Symbol for Bio-Techne Corp
The stock symbol (or 'ticker') for Bio-Techne Corp is "TECH."
What Stock Exchange Does Bio-Techne Corp Trade On?
Bio-Techne Corp is listed and trades on the NASDAQ stock exchange.
Is Bio-Techne Corp a Good Stock to Buy?
Determining whether Bio-Techne Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Bio-Techne Corp share price performance charts on this page. Our technical summary section provides analysis on Bio-Techne share price buy/sell indicators using real-time data (or discuss the Bio-Techne (TECH) stock price today with other investors in the Bio-Techne NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ TECH share price (ISIN: US09073M1045) to enhance your trading decisions with our free investment tools and resources.
What Is the Bio-Techne Corp Share Price Today?
The Bio-Techne share price today is 50.91.
What Is the Stock Symbol for Bio-Techne Corp
The stock symbol (or 'ticker') for Bio-Techne Corp is "TECH."
What Stock Exchange Does Bio-Techne Corp Trade On?
Bio-Techne Corp is listed and trades on the NASDAQ stock exchange.
Is Bio-Techne Corp a Good Stock to Buy?
Determining whether Bio-Techne Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
46.42
51.00
52 wk Range
45.12
72.16
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
46.4251.00
52 wk Range
45.1272.16
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.63%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.63%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TECH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
68.73
Upside
+35.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
- Bio-Techne stock hits 52-week low at 46.04 USD
- Investing.com
- Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Techne Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Analyst Ratings
10 Buy
4 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 68.73
(+35.00% Upside)
Bio-Techne Corp Earnings Call Summary for Q3/2026
- Bio-Techne Q3 FY2026 EPS of $0.53 missed estimates by 1.85%; revenue of $311.4M fell short by 1.49%, down 2% YoY organically.
- Stock surged 7.38% to $54.41 despite miss, driven by strategic brand consolidation and innovation in Spatial Biology Portfolio.
- Adjusted gross margin at 70.4%, down 120bps YoY but up 190bps sequentially; operating cash flow reached $86.7M with margin expansion.
- CEO highlighted COMET multi-omic platform growth; company focuses on Spatial Biology and Protein Sciences segments for future expansion.
- Risks include ongoing organic revenue decline, unfavorable product mix, macroeconomic pressures, and potential biotech funding volatility.
Last Updated: 08/05/2026, 08:42
Read Full TranscriptEarnings
Latest Release
06/05/2026
EPS / Forecast
0.53 / 0.54
Revenue / Forecast
311.4M / 316.12M
Compare TECH to Peers and Sector
Metrics to compare | TECH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTECHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 72.8x | 20.1x | −0.6x | |
PEG Ratio | −4.41 | 0.04 | 0.00 | |
Price/Book | 3.8x | 2.1x | 2.6x | |
Price / LTM Sales | 6.6x | 3.3x | 3.2x | |
Upside (Analyst Target) | 58.2% | 38.2% | 48.1% | |
Fair Value Upside | Unlock | 27.8% | 5.8% | Unlock |
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bio-Techne (NASDAQ: TECH) Share Price Today?
The Bio-Techne stock price today is 50.91 USD.
What Stock Exchange Does Bio-Techne (TECH) Trade On?
Bio-Techne is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Bio-Techne?
The stock symbol (also called a 'ticker') for Bio-Techne is "TECH."
Does Bio-Techne Pay Dividends? What’s The Current TECH Dividend Yield?
Yes, TECH Pays Dividends to its Shareholders. The current Bio-Techne dividend yield is 0.63%.
What Is the Current Bio-Techne Market Capitalisation?
As of today, Bio-Techne (NASDAQ: TECH) market cap is 7.97B USD.
What Is Bio-Techne's (TECH) Earnings Per Share (TTM)?
The Bio-Techne EPS is currently 0.70 (Trailing Twelve Months).
When Is the Next Bio-Techne Earnings Date?
Bio-Techne's next earnings report will be released on 11/08/2026.
Is TECH a Buy or Sell From a Technical Analyst Perspective?
Based on today's Bio-Techne moving averages and other technical indicators, the daily buy/sell signal for TECH stock is Strong Sell.
How Many Times Has Bio-Techne Stock Split?
Bio-Techne has split 3 times. (See the TECH stock split history page for full effective split date and price information.)
How Many Employees Does Bio-Techne Have?
Bio-Techne has 3100 employees, based on their latest Companies House report.
What is the current trading status of Bio-Techne (NASDAQ: TECH)?
As of 08/05/2026, Bio-Techne (TECH) is trading at a share price of 50.91 USD, with a previous close of 50.91 USD. The stock has fluctuated within a day range of 46.42 USD to 51.00 USD, while its 52-week range spans from 45.12 USD to 72.16 USD.
What Is Bio-Techne (TECH) Price Target According to Analysts?
The average 12-month price target for Bio-Techne is 68.73 USD, with a high estimate of 80 USD and a low estimate of 50 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +35.00% Upside potential.
What Is the TECH Premarket Price?
TECH's last pre-market stock price is 51.68 USD. The pre-market share volume is 8,840.00, and the stock has decreased by 0.77, or 1.51%.
What Is the TECH After Hours Price?
TECH's last after hours stock price is 50.50 USD, the stock has decreased by -0.41, or -0.81%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.